Comparison of 12 current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
X. Li
No relevant relationships to disclose
Q. Lin
No relevant relationships to disclose
M. Dong
No relevant relationships to disclose
X. Wu
No relevant relationships to disclose
L. Wei
No relevant relationships to disclose
J. Wen
No relevant relationships to disclose
X. Ma
No relevant relationships to disclose
Z. Chen
No relevant relationships to disclose